The DOI matches its Crossref record.
Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia
Open accessAbstract
Children with acute lymphoblastic leukemia (ALL) often develop bone pain, abnormal gait, and unusual fractures while in remission and receiving continuing chemotherapy. A prospective longitudinal cohort study was undertaken of bone mass and biochemical mineral status in 40 consecutive children (27 male, 13 female, aged 0.3–17.0 years) receiving therapy on the Dana-Farber Cancer Institute protocol 87–01. Radiography, lumbar spine dual-photon absorptiometry, and biochemical measurements of mineral status were performed at diagnosis and at 6-month intervals throughout 24 months of chemotherapy. Eleven patients were not completely evaluated (4 deaths and 7 off study). Radiographic evidence of osteopenia was observed in 10, 64, and 76% at diagnosis, 12 and 24 months, respectively. Fractures occurred in 39% of children during treatment. Reduction in bone mineral content (BMC), as measured by Z scores, occurred in 64% of patients and was most severe in those greater than 11 years of age at diagnosis. Reduction in BMC during the first 6 months of therapy had a positive predictive value of 64%, while an increase in BMC had a negative predictive value of 82% for subsequent fracture. By 6 months of therapy, 31/37 (84%) children were hypomagnesemic, of whom 16 (52%) were hypermagnesuric. Plasma osteocalcin was subnormal at diagnosis in 29/40 (73%) but increased to normal by 6 months of treatment. Vitamin D status was normal throughout, but plasma 1,25-dihydroxyvitamin D remained subnormal in greater than 70% of children. Urinary cross-link N-telopeptide was normal at diagnosis and became elevated in 58% of children by the end of therapy. Suppressed bone mineralization is evident at diagnosis in a minority of children with ALL. Skeletal morbidity and a reduction in bone mineral mass become more prevalent during treatment, with increased bone resorption, perhaps mainly as a consequence of corticosteroid administration. (J Bone Miner Res 1996;11:1774–1783)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Osteoporosis Due to Cancer Treatment: Pathogenesis and Management
Pfeilschifter, J., & Diel, I. J. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.7.1570 · Cited by 363
Bony Morbidity in Children Treated for Acute Lymphoblastic Leukemia
Strauss, A. J., Su, J. T., Dalton, V. M. K., Gelber, R. D., Sallan, S. E., & Silverman, L. B. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3066 · Cited by 252
The impact of corticosteroids on growth and bone health
Mushtaq, T. (2002) · Archives of Disease in Childhood · doi:10.1136/adc.87.2.93 · Cited by 169
Metadata
- Authors
- Halton, J. M., Dr. Atkinson, S. A., Fraher, L., Webber, C., Gill, G. J., Dawson, S., & Barr, R. D.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-11-01
- Volume
- 11
- Issue
- 11
- Pages
- 1774-1783
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2093312406
- Cited by
- 245
- References
- 0
- FWCI
- 9.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. https://app.cochat.ai/papers/10.1002/jbmr.5650111122
- The paper
- Halton, J. M., Dr. Atkinson, S. A., Fraher, L., Webber, C., Gill, G. J., Dawson, S., & Barr, R. D. (1996). Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650111122
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.